Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong
· Delayed Price · Currency is HKD 1.520
+0.030 (2.01%)
May 30, 2025, 11:31 AM HKT
HKG:0950 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 93.1 | 16.7 | 51.28 | 1,987 | 129.32 | Upgrade
|
| Depreciation & Amortization | 99.3 | 107.95 | 125.52 | 126.97 | 124.26 | Upgrade
|
| Other Amortization | 48.43 | 41.55 | 26.98 | 19.9 | 3.25 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.14 | -41.63 | -0.24 | -0.04 | -155.66 | Upgrade
|
| Asset Writedown & Restructuring Costs | 25.91 | 33.31 | 2.68 | 235.09 | 6.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.38 | 1.43 | 46.36 | -2,300 | 203.47 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.84 | 0.87 | 1.1 | 3.5 | 11.41 | Upgrade
|
| Stock-Based Compensation | 0.41 | 0.79 | 12.11 | 16.89 | 17.44 | Upgrade
|
| Provision & Write-off of Bad Debts | 13.7 | 1.28 | -0.26 | 90.28 | 1.18 | Upgrade
|
| Other Operating Activities | 11.07 | 26.16 | 33.1 | -33.8 | -50.97 | Upgrade
|
| Change in Accounts Receivable | -82.46 | 21.09 | 39.9 | -1.95 | 5.65 | Upgrade
|
| Change in Inventory | -7.22 | -61.96 | 43.28 | 43.34 | -147.46 | Upgrade
|
| Change in Accounts Payable | 69.98 | -26.82 | 39.48 | -11.35 | -6.51 | Upgrade
|
| Change in Other Net Operating Assets | -31.28 | -10.63 | -137.67 | 34.47 | 77.05 | Upgrade
|
| Operating Cash Flow | 242.01 | 110.08 | 283.63 | 210.68 | 218.91 | Upgrade
|
| Operating Cash Flow Growth | 119.85% | -61.19% | 34.63% | -3.76% | -45.27% | Upgrade
|
| Capital Expenditures | -43.96 | -29.43 | -17.46 | -50.7 | -138.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | 0.11 | 0.88 | 0.04 | 0.06 | Upgrade
|
| Cash Acquisitions | - | -0.02 | - | - | 0.47 | Upgrade
|
| Divestitures | - | - | - | - | -164.44 | Upgrade
|
| Sale (Purchase) of Intangibles | -141.54 | -110.72 | -196.37 | -320.03 | -219.74 | Upgrade
|
| Investment in Securities | -8.64 | -6.7 | -45.5 | -2.17 | -9.11 | Upgrade
|
| Other Investing Activities | 3.66 | 1.53 | 2.39 | 2.58 | 7.42 | Upgrade
|
| Investing Cash Flow | -190.23 | -145.22 | -256.05 | -370.28 | -523.74 | Upgrade
|
| Long-Term Debt Issued | 183.92 | 104.45 | 60 | 227.37 | 167.42 | Upgrade
|
| Total Debt Issued | 183.92 | 104.45 | 60 | 227.37 | 167.42 | Upgrade
|
| Long-Term Debt Repaid | -168.21 | -80.41 | -164.45 | -134.02 | -170.67 | Upgrade
|
| Total Debt Repaid | -168.21 | -80.41 | -164.45 | -134.02 | -170.67 | Upgrade
|
| Net Debt Issued (Repaid) | 15.71 | 24.04 | -104.45 | 93.35 | -3.25 | Upgrade
|
| Issuance of Common Stock | - | - | - | 3.54 | 0.45 | Upgrade
|
| Common Dividends Paid | -17.67 | -10.6 | -24.14 | -35.92 | -38.23 | Upgrade
|
| Other Financing Activities | - | - | - | - | 31.23 | Upgrade
|
| Financing Cash Flow | -1.96 | 13.44 | -128.6 | 60.97 | -9.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.51 | -0.08 | 12.79 | 0.96 | -3.68 | Upgrade
|
| Net Cash Flow | 49.32 | -21.77 | -88.23 | -97.67 | -318.32 | Upgrade
|
| Free Cash Flow | 198.06 | 80.65 | 266.18 | 159.99 | 80.52 | Upgrade
|
| Free Cash Flow Growth | 145.58% | -69.70% | 66.37% | 98.70% | -71.42% | Upgrade
|
| Free Cash Flow Margin | 14.15% | 7.66% | 21.58% | 12.64% | 6.62% | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.14 | 0.45 | 0.27 | 0.14 | Upgrade
|
| Cash Interest Paid | 12.77 | 10.4 | 6.24 | 3.79 | 4.72 | Upgrade
|
| Cash Income Tax Paid | 10.61 | 9.54 | -12.88 | 64.18 | 73.19 | Upgrade
|
| Levered Free Cash Flow | 49.6 | -44.97 | 68.9 | -177.85 | -240.68 | Upgrade
|
| Unlevered Free Cash Flow | 58.24 | -37.92 | 73.04 | -175.1 | -237.31 | Upgrade
|
| Change in Net Working Capital | -12.14 | 70.59 | -42.6 | -91.33 | 117.48 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.